Literature DB >> 32414805

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.

Sara Monti1, Carlomaurizio Montecucco2.   

Abstract

Entities:  

Keywords:  antirheumatic agents; arthritis; biological therapy

Year:  2020        PMID： 32414805     DOI： 10.1136/annrheumdis-2020-217738

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?

Authors:  Cristiana Sieiro Santos; Xenia Cásas Férnandez; Clara Moriano Morales; Elvira Díez Álvarez; Carolina Álvarez Castro; Alejandra López Robles; Trinidad Pérez Sandoval
Journal:  RMD Open       Date:  2021-01

Review 2.  Mental Health and Psychological Wellbeing in Rheumatoid Arthritis during COVID-19 - Can Physical Activity Help?

Authors:  Jet J C S Veldhuijzen van Zanten; Sally A M Fenton; Sophia Brady; George S Metsios; Joan L Duda; George D Kitas
Journal:  Mediterr J Rheumatol       Date:  2020-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.